Back
NovaBay Pharmaceuticals Vs. Doximity Industry Stock Comparison
Buy
52
NBY
NovaBay Pharmaceuticals
Last Price:
$0.61
Seasonality Move:
10.03%
Buy
68
DOCS
Doximity
Last Price:
$55.22
Seasonality Move:
-1.34%
Buy
52
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.63. The Score for NBY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.63The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
DOCS Stock Price Chart
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 57.67 | Buy |
Chaikin Money Flow: | 41257 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.54 - 0.6) | Buy |
Bollinger Bands (100): | (0.51 - 0.69) | Buy |
DOCS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.17 | Buy |
Relative Strength Index (14 RSI): | 49.52 | Sell |
Chaikin Money Flow: | 576551 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.42 - 56.46) | Sell |
Bollinger Bands (100): | (37.85 - 52.47) | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.57 | Buy |
20-day SMA: | 0.56 | Buy |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.73 | Sell |
8-day EMA: | 0.58 | Buy |
20-day EMA: | 0.58 | Buy |
50-day EMA: | 0.63 | Sell |
200-day EMA: | 4.42 | Sell |
DOCS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.36 | Sell |
20-day SMA: | 54.67 | Sell |
50-day SMA: | 50.73 | Buy |
200-day SMA: | 36.02 | Buy |
8-day EMA: | 55.01 | Sell |
20-day EMA: | 54.41 | Sell |
50-day EMA: | 51.06 | Buy |
200-day EMA: | 39.85 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.
Doximity Earnings Growth & DOCS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.10 per share.
NovaBay Pharmaceuticals Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Doximity Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |